StockMacro
Company, fund or insider

Help

Menu

Relay Therapeutics

$16.12 +14% in 6 monthsMarket cap $3.6B

RLAY on XNAS, Health Care, Relay Therapeutics, Inc., job postings

Measures activity, not value. Not investment advice.

Shares up 153% in a year, but insiders sold $120.7M in 90 days while short interest reached 20%.

  • BadNet loss $293.6M over 12 months; cash on hand $124.2M

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Industry
Biological products, (no diagnostic substances) (Health Care)
Employees
218
Website
relaytx.com
Listed
Nasdaq, US
Last results
4 Nov 2026
Next results
expected around 25 Feb 2027 (an estimate: a year ago it reported on 26 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $81.7M.
Quarter to 31 Dec 2021: revenue –, net income -$67.5MQuarter to 31 Mar 2022: revenue $419K, net income -$62.0MQuarter to 31 Mar 2022: revenue $419K, net income -$62.0MQuarter to 30 Jun 2022: revenue $365K, net income -$76.8MQuarter to 30 Jun 2022: revenue $365K, net income -$76.8MQuarter to 30 Sep 2022: revenue $344K, net income -$84.2MQuarter to 30 Sep 2022: revenue $344K, net income -$84.2MQuarter to 31 Dec 2022: revenue $253K, net income -$67.5MQuarter to 31 Dec 2022: revenue $253K, net income -$67.5MQuarter to 31 Mar 2023: revenue $226K, net income -$94.2MQuarter to 31 Mar 2023: revenue $226K, net income -$94.2MQuarter to 30 Jun 2023: revenue $119K, net income -$98.5MQuarter to 30 Jun 2023: revenue $119K, net income -$98.5MQuarter to 30 Sep 2023: revenue $25.2M, net income -$65.7MQuarter to 30 Sep 2023: revenue $25.2M, net income -$65.7MQuarter to 31 Dec 2023: revenue –, net income -$83.5MQuarter to 31 Mar 2024: revenue $10.0M, net income -$81.4MQuarter to 31 Mar 2024: revenue $10.0M, net income -$81.4MQuarter to 30 Jun 2024: revenue $0, net income -$92.2MQuarter to 30 Jun 2024: revenue $0, net income -$92.2MQuarter to 30 Sep 2024: revenue $0, net income -$88.1MQuarter to 30 Sep 2024: revenue $0, net income -$88.1MQuarter to 31 Dec 2024: revenue $0, net income -$76.0MQuarter to 31 Dec 2024: revenue $0, net income -$76.0MQuarter to 31 Mar 2025: revenue $7.7M, net income -$77.1MQuarter to 31 Mar 2025: revenue $7.7M, net income -$77.1MQuarter to 30 Jun 2025: revenue $677K, net income -$70.4MQuarter to 30 Jun 2025: revenue $677K, net income -$70.4MQuarter to 30 Sep 2025: revenue $0, net income -$74.1MQuarter to 30 Sep 2025: revenue $0, net income -$74.1MQuarter to 31 Dec 2025: revenue $7.0M, net income -$54.9MQuarter to 31 Dec 2025: revenue $7.0M, net income -$54.9MQuarter to 31 Mar 2026: revenue $3.0M, net income -$73.3MQuarter to 31 Mar 2026: revenue $3.0M, net income -$73.3MQuarter to 30 Jun 2026: revenue $350K, net income -$83.7MQuarter to 30 Jun 2026: revenue $350K, net income -$83.7MQuarter to 30 Sep 2026: revenue –, net income -$81.7M
31 Dec 2021RevenueNet incomeNet losstallest bar $98.5M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026–-$81.7M
30 Jun 2026$350K-$83.7M
31 Mar 2026$3.0M-$73.3M
31 Dec 2025$7.0M-$54.9M
30 Sep 2025$0-$74.1M
30 Jun 2025$677K-$70.4M
31 Mar 2025$7.7M-$77.1M
31 Dec 2024$0-$76.0M
30 Sep 2024$0-$88.1M
30 Jun 2024$0-$92.2M
31 Mar 2024$10.0M-$81.4M
31 Dec 2023–-$83.5M
30 Sep 2023$25.2M-$65.7M
30 Jun 2023$119K-$98.5M
31 Mar 2023$226K-$94.2M
31 Dec 2022$253K-$67.5M
30 Sep 2022$344K-$84.2M
30 Jun 2022$365K-$76.8M
31 Mar 2022$419K-$62.0M
31 Dec 2021–-$67.5M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – $8.4M
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +8.2%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$293.6M -$297.6M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$1.50 -$1.72
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 70.4%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -98.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -47.8%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -41.2% -58.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $124.2M $91.6M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $0 $0
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$124.2M (net cash) -$91.6M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.0 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $3.71
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 21.6
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 8.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 6.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 4.3 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Relay TherapeuticsRLAY (this company) $3.6Bloss–––
Tarsus PharmaceuticalsTARS $3.6Bloss5.3+86%-103%
CRISPR Therapeutics AGCRSP $3.8Bloss151-34%–
Iovance BiotherapeuticsIOVA $3.2Bloss8.4+51%-58.2%
Denali TherapeuticsDNLI $3.0Bloss–––
VericelVCEL $2.9B88.19.1+25%10.3%

Insider buy/sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$120.7M

bought $0, sold $120.7M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+1.6%

259 13F filers vs 255

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

231.1M shares held by 13F filers (30 Sep 2026) of 221.0M outstanding (30 Oct 2026); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

20%

43.6M shares sold short (30 Oct 2026) of 221.0M outstanding (30 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

20.7

43.6M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-0.9%

44.0M shares sold short in the report before, 43.6M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

62%

62% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 56%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

19

19 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

19×

19 articles in the last 7 days; its usual week has 1.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Short interest 43.6M, 1.9× a year earlier

Price $16.12 on 20 Nov 2026, +153% over 12 months (12-month range $6.38 to $20.75)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $130.7M in the last 12 months (the 12 months before: -$6.6M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 0 published in the last 12 months, -100% on the 12 months before.
Revenue per quarter. Revenue $350K in the latest quarter, -48% on a year earlier.
Capital spending per quarter. Capital spending $0 in the latest quarter.
Institutional holders (13F filers). 259 13F filers reported holding it in the latest 13F quarter, +38% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
13 Oct 2026Sharp changeShort interest spike: short interest spike, 46.7M vs usual 23.6M (2026-09-30); 2.1x the same period a year earlier
29 Sep 2026Sharp changeShort interest spike: short interest spike, 44.5M vs usual 22.9M (2026-09-15); 2.0x the same period a year earlier
15 Sep 2026Sharp changeShort interest spike: short interest spike, 43.6M vs usual 22.7M (2026-08-31); 1.9x the same period a year earlier
1 Sep 2026Sharp changeShort interest spike: short interest spike, 41.4M vs usual 22.7M (2026-08-14); 1.8x the same period a year earlier
18 Aug 2026Sharp changeShort interest spike: short interest spike, 40.3M vs usual 22.6M (2026-07-31); 1.8x the same period a year earlier
16 Jun 2026Sharp changeShort interest spike: short interest spike, 34.4M vs usual 22.4M (2026-05-29); 1.5x the same period a year earlier
6 Nov 20258-K and other filingsDirector or officer change
6 Nov 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
11 Jun 20258-K and other filingsDirector or officer change
11 Jun 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
4 Jun 20258-K and other filingsA major agreement ended
19 Nov 2024Sharp changeMany funds opening a new position: many funds opening a new position, 41 vs usual 24.50 (2024-09-30); 2.2x the same period a year earlier
16 Jul 20248-K and other filingsA major agreement ended
7 May 2024Sharp changeQuarterly revenue change: quarterly revenue change, 10.0M vs usual 354K (2024-03-31); 44.3x the same period a year earlier
10 Jan 20248-K and other filingsPrivate placement of securities (Form D)
7 Nov 2023Sharp changeQuarterly revenue change: quarterly revenue change, 25.2M vs usual 354K (2023-09-30); 73.3x the same period a year earlier
27 Jul 20228-K and other filingsDirector or officer change
27 Jul 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
9 Dec 20218-K and other filingsDirector or officer change
9 Dec 2021Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
Insider net buying (open market)
Month from 1 Dec 2021: -$50K published
Month from 1 Feb 2022: -$482K published
Month from 1 Mar 2022: -$1.1M published
Month from 1 Apr 2022: -$3.2M published
Month from 1 May 2022: -$414K published
Month from 1 Jun 2022: -$198K published
Month from 1 Jul 2022: -$240K published
Month from 1 Aug 2022: -$535K published
Month from 1 Sep 2022: -$3.7M published
Month from 1 Oct 2022: -$1.1M published
Month from 1 Nov 2022: -$1.1M published
Month from 1 Dec 2022: -$25K published
Month from 1 Jan 2023: -$1.9M published
Month from 1 Feb 2023: -$966K published
Month from 1 Mar 2023: -$27K published
Month from 1 May 2023: -$43K published
Month from 1 Jun 2023: -$18K published
Month from 1 Aug 2023: -$87K published
Month from 1 Sep 2023: -$12K published
Month from 1 Nov 2023: -$49K published
Month from 1 Dec 2023: -$21K published
Month from 1 Feb 2024: -$84K published
Month from 1 Mar 2024: -$14K published
Month from 1 Apr 2024: -$47K published
Month from 1 Jun 2024: -$542K published
Month from 1 Jul 2024: -$857K published
Month from 1 Aug 2024: -$484K published
Month from 1 Oct 2024: -$148K published
Month from 1 Dec 2024: -$500K published
Month from 1 Jan 2025: -$3.2M published
Month from 1 Feb 2025: -$818K published
Month from 1 Apr 2025: -$201K published
Month from 1 May 2025: -$235K published
Month from 1 Jul 2025: -$543K published
Month from 1 Oct 2025: -$683K published
Month from 1 Nov 2025: -$435K published
Month from 1 Jan 2026: -$724K published
Month from 1 Mar 2026: -$178K published
Month from 1 Apr 2026: -$257K published
Month from 1 May 2026: -$275K published
Month from 1 Jun 2026: -$4.8M published
Month from 1 Jul 2026: -$2.5M published
Month from 1 Aug 2026: -$117.8M published
Month from 1 Sep 2026: -$1.4M published
Month from 1 Oct 2026: -$1.3M published
Month from 1 Nov 2026: -$1.5M published
H-1B/E-3 applications certified
Quarter from 1 Apr 2022: 4 published
Quarter from 1 Jul 2022: 1 published
Quarter from 1 Apr 2023: 1 published
Quarter from 1 Jul 2023: 1 published
Quarter from 1 Jan 2024: 2 published
Quarter from 1 Apr 2024: 2 published
Quarter from 1 Jul 2024: 3 published
Quarter from 1 Apr 2025: 1 published
Quarter from 1 Jul 2025: 1 published
Revenue per quarter
Quarter ended 31 Mar 2022: $419K, -56% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $365K, -57% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $344K, -48% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $253K; public on 24 Feb 2023
Quarter ended 31 Mar 2023: $226K, -46% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $119K, -67% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $25.2M, +7226% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Mar 2024: $10.0M, +4328% on a year earlier; public on 3 May 2024
Quarter ended 30 Jun 2024: $0, -100% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2024: $0, -100% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2024: $0; public on 27 Feb 2025
Quarter ended 31 Mar 2025: $7.7M, -23% on a year earlier; public on 6 May 2025
Quarter ended 30 Jun 2025: $677K; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $0; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $7.0M; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $3.0M, -61% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $350K, -48% on a year earlier; public on 7 Aug 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $880K, +1275% on a year earlier; public on 25 Feb 2022
Quarter ended 31 Mar 2022: $2.8M, +487% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $1.9M, +390% on a year earlier; public on 5 Aug 2022
Quarter ended 30 Sep 2022: $2.1M, +21% on a year earlier; public on 4 Nov 2022
Quarter ended 31 Dec 2022: $2.3M, +163% on a year earlier; public on 24 Feb 2023
Quarter ended 31 Mar 2023: $1.9M, -31% on a year earlier; public on 5 May 2023
Quarter ended 30 Jun 2023: $1.5M, -19% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $590K, -72% on a year earlier; public on 3 Nov 2023
Quarter ended 31 Dec 2023: $118K, -95% on a year earlier; public on 23 Feb 2024
Quarter ended 31 Mar 2024: $1.8M, -7.0% on a year earlier; public on 3 May 2024
Quarter ended 30 Sep 2024: $227K, -62% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Mar 2025: $384K, -78% on a year earlier; public on 6 May 2025
Quarter ended 30 Jun 2025: $26K; public on 8 Aug 2025
Quarter ended 30 Sep 2026: $0; public on 5 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 120; public on 14 Feb 2022
31 Mar 2022 report: 134; public on 16 May 2022
30 Jun 2022 report: 142; public on 15 Aug 2022
30 Sep 2022 report: 151; public on 14 Nov 2022
31 Dec 2022 report: 156; public on 14 Feb 2023
31 Mar 2023 report: 150; public on 15 May 2023
30 Jun 2023 report: 153; public on 14 Aug 2023
30 Sep 2023 report: 161; public on 14 Nov 2023
31 Dec 2023 report: 167; public on 14 Feb 2024
31 Mar 2024 report: 181; public on 15 May 2024
30 Jun 2024 report: 168; public on 14 Aug 2024
30 Sep 2024 report: 189; public on 14 Nov 2024
31 Dec 2024 report: 198; public on 14 Feb 2025
31 Mar 2025 report: 202; public on 15 May 2025
30 Jun 2025 report: 199; public on 14 Aug 2025
30 Sep 2025 report: 188; public on 14 Nov 2025
31 Dec 2025 report: 217; public on 17 Feb 2026
31 Mar 2026 report: 235; public on 15 May 2026
30 Jun 2026 report: 255; public on 14 Aug 2026
30 Sep 2026 report: 259; public on 16 Nov 2026

What is unusual now

  • Made public in the last 90 days: it had 43.6M shares sold short in the 31 Aug 2026 report, 1.9× the same report last year; it also had 41.4M shares sold short in the 14 Aug 2026 report, 1.8× the same report last year. 4 sharp changes in all.
  • Short interest spike: had 40.3M shares sold short in the 31 Jul 2026 report, 1.8× the same report last year Public on 12 Aug 2026.
  • Insider net buying (open market): Insiders sold a net $130.7M in the last 12 months (the 12 months before: -$6.6M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 0 published in the last 12 months, -100% on the 12 months before.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 13 sales, $120.7M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
20 Nov 2026Sanjiv PatelPresident and CEOSellplanned in advance (10b5-1)48,202$16.13$777KForm 4
20 Nov 2026Donald A BergstromPresident, R&DSellplanned in advance (10b5-1)10,269$16.51$170KForm 4
20 Nov 2026Thomas CatinazzoChief Financial OfficerSellplanned in advance (10b5-1)32,717$16.51$540KForm 4
30 Oct 2026Peter RahmerSee remarksSell753$18.62$14KForm 4
30 Oct 2026Donald A BergstromPresident, R&DSell2,252$18.62$42KForm 4
30 Oct 2026Thomas CatinazzoChief Financial OfficerSell1,469$18.62$27KForm 4
8 Oct 2026Sanjiv PatelPresident and CEOSellplanned in advance (10b5-1)48,199$18.10$872KForm 4
8 Oct 2026Thomas CatinazzoChief Financial OfficerSellplanned in advance (10b5-1)17,717$18.59$329KForm 4

259 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 28 opened a position, 29 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
FMR LLC (Fidelity)24.2M11.0%$437.5M+4.1M+21%
SB Investment Advisers (Uk) Ltd21.9M9.91%$395.4M-6.0M-22%
T. Rowe Price Investment Management, Inc.17.9M8.09%+16.0M+833%
BlackRock, Inc.16.7M7.56%$301.4M+1.4M+9.2%
Casdin Capital, LLC16.0M7.26%$289.4MNo change
Perceptive Advisors LLC12.7M5.76%$229.8M-1.4M-9.8%
Commodore Capital LP12.0M5.43%$216.6MNo change
State Street Corp9.2M4.14%$165.2M-974K-9.6%
Vanguard Capital Management LLC9.0M4.08%$162.7M+47K+0.5%
Nextech Invest Ltd.6.8M3.07%$122.3MNo change

Company events

All 23 company events

In 12 months: 2 major agreements. Results releases and routine reports are left out.

FiledWhat happenedSource
6 Aug 2026Signed a major agreement8-K
21 May 2026Signed a major agreement8-K
6 Nov 2025Director or officer change8-K
11 Jun 2025Director or officer change8-K
4 Jun 2025Signed a major agreement; A major agreement ended8-K
11 Sep 2024Signed a major agreement8-K
16 Jul 2024A major agreement ended8-K
10 Jan 2024Private placement of securities (Form D)$30.0M sold of $30.0M offeredD

The 5 newest of 152 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 10 Oct 2026Short interest and volume change

    had 46.7M shares sold short in the 30 Sep 2026 report, 2.1× the same report last year.

    Same report last year: 22.6M; its normal report is 23.6M.

    See the evidence
    This period
    46.7M (the 30 Sep 2026 report)
    Normal report (median of 24 earlier)
    23.6M
    Typical spread (median absolute deviation)
    3.8M
    How far from its usual level
    +4.1
    Same report last year
    22.6M
    History used
    2,252 days
    2025-09-30: 22.6M2025-10-15: 21.9M2025-10-31: 17.9M2025-11-14: 21.4M2025-11-28: 23.2M2025-12-15: 20.3M2025-12-31: 22.2M2026-01-15: 22.4M2026-01-30: 24.0M2026-02-13: 19.9M2026-02-27: 19.4M2026-03-13: 19.8M2026-03-31: 21.9M2026-04-15: 27.0M2026-04-30: 27.4M2026-05-15: 28.8M2026-05-29: 34.4M2026-06-15: 38.1M2026-06-30: 43.0M2026-07-15: 42.6M2026-07-31: 40.3M2026-08-14: 41.4M2026-08-31: 43.6M2026-09-15: 44.5M2026-09-30: 46.7M
    the 30 Sep 2026 report24 earlier reportsnormal: 23.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 25 Sep 2026Short interest and volume change

    had 44.5M shares sold short in the 15 Sep 2026 report, 2.0× the same report last year.

    Same report last year: 22.5M; its normal report is 22.9M.

    See the evidence
    This period
    44.5M (the 15 Sep 2026 report)
    Normal report (median of 24 earlier)
    22.9M
    Typical spread (median absolute deviation)
    3.3M
    How far from its usual level
    +4.5
    Same report last year
    22.5M
    History used
    2,237 days
    2025-09-15: 22.5M2025-09-30: 22.6M2025-10-15: 21.9M2025-10-31: 17.9M2025-11-14: 21.4M2025-11-28: 23.2M2025-12-15: 20.3M2025-12-31: 22.2M2026-01-15: 22.4M2026-01-30: 24.0M2026-02-13: 19.9M2026-02-27: 19.4M2026-03-13: 19.8M2026-03-31: 21.9M2026-04-15: 27.0M2026-04-30: 27.4M2026-05-15: 28.8M2026-05-29: 34.4M2026-06-15: 38.1M2026-06-30: 43.0M2026-07-15: 42.6M2026-07-31: 40.3M2026-08-14: 41.4M2026-08-31: 43.6M2026-09-15: 44.5M
    the 15 Sep 2026 report24 earlier reportsnormal: 22.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 11 Sep 2026Short interest and volume change

    had 43.6M shares sold short in the 31 Aug 2026 report, 1.9× the same report last year.

    Same report last year: 22.7M; its normal report is 22.7M.

    See the evidence
    This period
    43.6M (the 31 Aug 2026 report)
    Normal report (median of 24 earlier)
    22.7M
    Typical spread (median absolute deviation)
    2.8M
    How far from its usual level
    +5.0
    Same report last year
    22.7M
    History used
    2,222 days
    2025-08-29: 22.7M2025-09-15: 22.5M2025-09-30: 22.6M2025-10-15: 21.9M2025-10-31: 17.9M2025-11-14: 21.4M2025-11-28: 23.2M2025-12-15: 20.3M2025-12-31: 22.2M2026-01-15: 22.4M2026-01-30: 24.0M2026-02-13: 19.9M2026-02-27: 19.4M2026-03-13: 19.8M2026-03-31: 21.9M2026-04-15: 27.0M2026-04-30: 27.4M2026-05-15: 28.8M2026-05-29: 34.4M2026-06-15: 38.1M2026-06-30: 43.0M2026-07-15: 42.6M2026-07-31: 40.3M2026-08-14: 41.4M2026-08-31: 43.6M
    the 31 Aug 2026 report24 earlier reportsnormal: 22.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 26 Aug 2026Short interest and volume change

    had 41.4M shares sold short in the 14 Aug 2026 report, 1.8× the same report last year.

    Same report last year: 22.7M; its normal report is 22.7M.

    See the evidence
    This period
    41.4M (the 14 Aug 2026 report)
    Normal report (median of 24 earlier)
    22.7M
    Typical spread (median absolute deviation)
    2.6M
    How far from its usual level
    +4.9
    Same report last year
    22.7M
    History used
    2,205 days
    2025-08-15: 22.7M2025-08-29: 22.7M2025-09-15: 22.5M2025-09-30: 22.6M2025-10-15: 21.9M2025-10-31: 17.9M2025-11-14: 21.4M2025-11-28: 23.2M2025-12-15: 20.3M2025-12-31: 22.2M2026-01-15: 22.4M2026-01-30: 24.0M2026-02-13: 19.9M2026-02-27: 19.4M2026-03-13: 19.8M2026-03-31: 21.9M2026-04-15: 27.0M2026-04-30: 27.4M2026-05-15: 28.8M2026-05-29: 34.4M2026-06-15: 38.1M2026-06-30: 43.0M2026-07-15: 42.6M2026-07-31: 40.3M2026-08-14: 41.4M
    the 14 Aug 2026 report24 earlier reportsnormal: 22.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 12 Aug 2026Short interest and volume change

    had 40.3M shares sold short in the 31 Jul 2026 report, 1.8× the same report last year.

    Same report last year: 22.4M; its normal report is 22.6M.

    See the evidence
    This period
    40.3M (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    22.6M
    Typical spread (median absolute deviation)
    1.9M
    How far from its usual level
    +6.4
    Same report last year
    22.4M
    History used
    2,191 days
    2025-07-31: 22.4M2025-08-15: 22.7M2025-08-29: 22.7M2025-09-15: 22.5M2025-09-30: 22.6M2025-10-15: 21.9M2025-10-31: 17.9M2025-11-14: 21.4M2025-11-28: 23.2M2025-12-15: 20.3M2025-12-31: 22.2M2026-01-15: 22.4M2026-01-30: 24.0M2026-02-13: 19.9M2026-02-27: 19.4M2026-03-13: 19.8M2026-03-31: 21.9M2026-04-15: 27.0M2026-04-30: 27.4M2026-05-15: 28.8M2026-05-29: 34.4M2026-06-15: 38.1M2026-06-30: 43.0M2026-07-15: 42.6M2026-07-31: 40.3M
    the 31 Jul 2026 report24 earlier reportsnormal: 22.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 10 Jun 2026Short interest and volume change

    had 34.4M shares sold short in the 29 May 2026 report, 1.5× the same report last year.

    Same report last year: 22.6M; its normal report is 22.4M.

    See the evidence
    This period
    34.4M (the 29 May 2026 report)
    Normal report (median of 24 earlier)
    22.4M
    Typical spread (median absolute deviation)
    820K
    How far from its usual level
    +5.4
    Same report last year
    22.6M
    History used
    2,128 days
    2025-05-30: 22.6M2025-06-13: 22.5M2025-06-30: 21.5M2025-07-15: 21.5M2025-07-31: 22.4M2025-08-15: 22.7M2025-08-29: 22.7M2025-09-15: 22.5M2025-09-30: 22.6M2025-10-15: 21.9M2025-10-31: 17.9M2025-11-14: 21.4M2025-11-28: 23.2M2025-12-15: 20.3M2025-12-31: 22.2M2026-01-15: 22.4M2026-01-30: 24.0M2026-02-13: 19.9M2026-02-27: 19.4M2026-03-13: 19.8M2026-03-31: 21.9M2026-04-15: 27.0M2026-04-30: 27.4M2026-05-15: 28.8M2026-05-29: 34.4M
    the 29 May 2026 report24 earlier reportsnormal: 22.4M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 6 Nov 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  8. 6 Nov 2025Filings record

    Director or officer change

  9. 11 Jun 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  10. 11 Jun 2025Filings record

    Director or officer change

  11. 4 Jun 2025Filings record

    A major agreement ended

  12. 14 Nov 2024Institutional holdings change

    saw 41 13F filers open a new position in the quarter ended 30 Sep 2024, 2.2× the same quarter last year.

    Same quarter last year: 19; its normal quarter is 24.5.

    See the evidence
    This period
    41 (the quarter ended 30 Sep 2024)
    Normal quarter (median of 8 earlier)
    24.5
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +5.5
    Same quarter last year
    19
    History used
    1,461 days
    2022-09-30: 272022-12-31: 252023-03-31: 222023-06-30: 262023-09-30: 192023-12-31: 242024-03-31: 262024-06-30: 202024-09-30: 41
    the quarter ended 30 Sep 20248 earlier quartersnormal: 24.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  13. 16 Jul 2024Filings record

    A major agreement ended

  14. 7 May 2024Financials change

    reported revenue of $10.0M for the quarter ended 31 Mar 2024, 44× the same quarter last year.

    Same quarter last year: $226K; its normal quarter is $354K.

    See the evidence
    This period
    $10.0M (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    $354K
    Typical spread (median absolute deviation)
    $115K
    How far from its usual level
    +9.7
    Same quarter last year
    $226K
    History used
    1,096 days
    2021-12-31: $567K2022-03-31: $419K2022-06-30: $365K2022-09-30: $344K2022-12-31: $253K2023-03-31: $226K2023-06-30: $119K2023-09-30: $25.2M2024-03-31: $10.0M
    the quarter ended 31 Mar 20248 earlier quartersnormal: $354K

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  15. 10 Jan 2024Filings record

    Private placement of securities (Form D)

  16. 7 Nov 2023Financials change

    reported revenue of $25.2M for the quarter ended 30 Sep 2023, 73× the same quarter last year.

    Same quarter last year: $344K; its normal quarter is $354K.

    See the evidence
    This period
    $25.2M (the quarter ended 30 Sep 2023)
    Normal quarter (median of 8 earlier)
    $354K
    Typical spread (median absolute deviation)
    $115K
    How far from its usual level
    +24.8
    Same quarter last year
    $344K
    History used
    913 days
    2021-09-30: $666K2021-12-31: $567K2022-03-31: $419K2022-06-30: $365K2022-09-30: $344K2022-12-31: $253K2023-03-31: $226K2023-06-30: $119K2023-09-30: $25.2M
    the quarter ended 30 Sep 20238 earlier quartersnormal: $354K

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  17. 27 Jul 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 27 Jul 2022Filings record

    Director or officer change

  19. 9 Dec 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  20. 9 Dec 2021Filings record

    Director or officer change

  21. 28 Apr 2021Filings record

    Registered new securities for sale (S-1)

  22. 22 Jul 2020Insiders change

    had 4 insiders buy $1.7M of its shares on the open market within 30 days (4 filings).

    Who bought: Murcko Mark, Adams Brian, Patel Sanjiv, Ingram Douglas S.

    See the evidence (4 source records)
    Independent buyers
    4
    Purchase filings (Form 4, code P)
    4
    Total bought
    $1.7M
    Window
    22 Jun 2020 to 22 Jul 2020

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  23. 22 Jul 2020Insiders record

    INGRAM DOUGLAS S (director) bought 25,000 shares of RLAY ($500,000) (dated 21 Jul 2020)

  24. 22 Jul 2020Insiders record

    Patel Sanjiv (President and CEO) bought 25,000 shares of RLAY ($500,000) (dated 21 Jul 2020)

  25. 22 Jul 2020Insiders record

    Adams Brian (General Counsel) bought 10,000 shares of RLAY ($200,000) (dated 21 Jul 2020)

  26. 22 Jul 2020Insiders record

    Rubin Jami (director) bought 25,000 shares of RLAY [same transaction as an earlier filing] (dated 21 Jul 2020)

  27. 22 Jul 2020Insiders record

    Murcko Mark (director) bought 25,000 shares of RLAY ($500,000) (dated 21 Jul 2020)

  28. 15 Jul 2020Filings record

    Registered new securities for sale (S-1)

  29. 15 Jul 2020Filings record

    Registered new securities for sale (S-1)

  30. 14 Jul 2020Filings record

    Registered new securities for sale (S-1)

  31. 9 Jul 2020Filings record

    Registered new securities for sale (S-1)

  32. 24 Jun 2020Filings record

    Registered new securities for sale (S-1)

Not listed: 283 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001812364
Ticker
RLAY
Domain
relaytx.com
Employer name
Relay Therapeutics, Inc. (1 unverified)
Hq location
MA|CAMBRIDGE|02139 (1 unverified)
Name
EX-21.1, Relay Securities Corporation, Relay Therapeutics, Inc., rlay-ex21_1.htm
Wikidata
Q106411735
  • DOL H-1B labor condition applications and PERM certifications107 data points16 Mar 2020 to 1 Apr 2026
  • SEC Form 13F institutional holdings225 data points30 Sep 2020 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)93 records24 Jun 2020 to 4 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)419 data points31 Dec 2018 to 30 Oct 2026
  • SEC Form 4 insider transactions208 records, 344 data points21 Jul 2020 to 20 Nov 2026
  • FINRA short interest (twice monthly)449 data points31 Jul 2020 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)3194 data points16 Jul 2020 to 20 Nov 2026